Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$3.75M Sell
77,602
-5,235
-6% -$260K 0.54% 14
2017
Q2
$4.15M Buy
82,837
+31,540
+61% +$1.44M 0.6% 8
2017
Q1
$2.29M Buy
51,297
+16,640
+48% +$693K 0.45% 30
2016
Q4
$1.33M Sell
34,657
-5,618
-14% -$220K 0.31% 88
2016
Q3
$1.58M Buy
40,275
+11,704
+41% +$477K 0.33% 63
2016
Q2
$1.17M Buy
28,571
+6,790
+31% +$271K 0.28% 103
2016
Q1
$891K Sell
21,781
-2,901
-12% -$107K 0.23% 153
2015
Q4
$902K Sell
24,682
-7,296
-23% -$279K 0.26% 144
2015
Q3
$1.16M Sell
31,978
-22,333
-41% -$859K 0.27% 126
2015
Q2
$2.19M Sell
54,311
-16,881
-24% -$732K 0.28% 149
2015
Q1
$3.07M Buy
71,192
+25,923
+57% +$1.12M 0.42% 79
2014
Q4
$2.04M Buy
+45,269
New +$1.84M 0.41% 85

Other funds holding ORCL

GAM Systematic's ORCL Position: Q3 2017 in Review

GAM Systematic reduced its Oracle (ORCL) stake by 6.3% in Q3 2017, selling an estimated $260K and leaving 77,602 shares worth $3.75M. The position accounts for 0.54% of the portfolio, ranked #14.

GAM Systematic first reported a position in ORCL in Q4 2014 and has held it in 12 quarters since. The position peaked at $4.15M in Q2 2017. 1,641 funds tracked by Wall St. Rank hold ORCL as of Q3 2017.

  • GAM Systematic held 77,602 shares of Oracle worth $3.75M as of Q3 2017.
  • GAM Systematic sold 5,235 Oracle shares in Q3 2017, an estimated $260K.
  • Oracle made up 0.54% of GAM Systematic's portfolio in Q3 2017, its #14 holding.
  • GAM Systematic first reported a position in Oracle in Q4 2014 and has held it in 12 quarters since.
  • GAM Systematic's Oracle position peaked at $4.15M in Q2 2017.
  • 1,641 funds tracked by Wall St. Rank held Oracle as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.